Menu
At Sapala, we offer flexible engagement models to suit the diverse needs of our clients in the Medicinal Chemistry and Nucleic Acid Chemistry domain.
Our expertise in organic synthesis enables us to accommodate various research projects through the following modes:
As a leading Contract Research Organization (CRO), our Full Time Equivalent (FTE) service model offers clients direct access to dedicated scientists, seamlessly integrated into your research projects. This model is ideal for organizations seeking long-term, collaborative partnerships. Our team works as an extension of your R&D efforts.
By embedding our team into your project workflow, we ensure a deep understanding of your objectives, delivering tailored, high-quality solutions that align with your specific goals. With expertise in both gram-scale and kilogram-scale synthesis, we deliver efficient and successful outcomes across a broad spectrum of research requirements.
Under the Fee For Service (FFS) model, we provide tailored solutions for specific research assignments on a project basis.
At Sapala, we stand as India’s leading CDMO specializing in Medicinal and Nucleic Acid Chemistry, fortified by over 100 years of combined leadership experience in Small molecule NCE, Oligonucleotide and Phosphoramidite synthesis. Our recent acquisition by Suven Pharma empowers us to leverage over three decades of CDMO expertise from the Suven Pharma legacy, ensuring unparalleled service and innovation.
Our team’s extensive experience in oligonucleotide and phosphoramidite synthesissynthesis of modified nucleosides and nucleotides allows us to deliver high-quality nucleic acidsOligo nucleotides tailored for diverse research and therapeutic applications. We utilize cutting-edge methodologies to achieve optimal purity and yield.
We prioritize collaboration with clients to develop and optimize processes that ensure efficiency and scalability. Our industry experience equips us to effectively address challenges, ensuring timely delivery and compliance with regulatory standards.
Our analytical team employs state-of-the-art techniques for thorough characterization and quality control. We conduct comprehensive stability studies and validation, providing you with confidence in the integrity of our products.
Our knowledgeable regulatory team guides you through the complexities of compliance, ensuring adherence to both local and international regulations throughout the project lifecycle.
Every project presents unique challenges, and we pride ourselves on our flexibility. Our customized solutions are designed to meet your specific needs while maintaining the highest quality standards.
With over 30 years of combined CDMO experience from Suven Pharma and Cohance, we bring best practices and proven strategies to our clients.
Our combined operations span 13 manufacturing sites, including 8 USFDA/EDQM accredited facilities, and boast over 2650 KL of reactor capacity, ensuring scalability and reliability.
We implement rigorous quality assurance protocols to guarantee the safety and reliability of every product.
We value strong relationships and work closely with our clients to achieve their goals.
Our streamlined processes enable us to meet deadlines without sacrificing quality.
We offer a comprehensive range of specialized nucleic acid building blocks, heterocyclic compounds, drug delivery compounds, and for Drug development. We are committed to delivering quality and timely analytical services to our clients across Hyderabad, Bengaluru, Mumbai, Ahmedabad, and Japan. Our clientele includes manufacturers of pharmaceutical dosage forms, APIs, drug intermediates, fine chemicals, CROs, and other chemical manufacturers. As an ethical and professional service provider, we prioritize confidentiality and welcome clients to inspect or audit our facilities, ensuring they are satisfied with the quality of our services.
Our analytical services are designed, developed, and validated using advanced methods, reflecting our expertise in Analytical Chemistry. We specialize in handling a wide range of analytical work related to Organic Synthesis, ensuring precision and reliability in every project.
At Sapala Organics, we offer a fully customized model designed to meet each customer’s unique requirements. Starting from process development to scale-up, we provide a flexible “mix-and-match” approach, whether it’s creating a technical document or scaling production. As the invisible hand behind drug discovery, we’ve supported clients ranging from large biotech companies to academic institutions. For instance, in 2007, we partnered with a company to produce just 500 grams of a specialized compound. By 2022, we scaled that production to 26 kilograms of highly complex Amidites thereby demonstrating our ability to adapt and deliver at every stage of the development process.
